lindas have a posse
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree
Multiple resections are futile without DCVax. Surgery alone does nothing for Glioblastoma.
Management are working 24/7 on approval. That's all that matters.
They will be at $5 post DCVax approval.
I agree supernovae imminent.
"DCVax or Death" should be on the next tote bag.
It screams wash trading, spoofing, and longs who are already overweight on the stock not selling!
Move your money then buy.
Landmark Trial Results
Thermo manages a huge portfolio. He probably isn't worried about NWBO nor obsessed with it daily.
My mamma said ain't ain't a word.
Landmark Trial Results!
JAMA!
MHRA Trial Endorsement (PIP)!
MHRA-endorsed Manufacturing (MIA)!
Global Patent Protection!
My nearly 6000K shares should be worth $40M or more once Northwest Biotherapeutics obtains global approval on nGBM and rGBM indications.
I see no reason to sell my shares since I can borrow against them once NWBO are off OTC.
In my personal opinion as a retail investor representing myself alone, and not providing investment advice, longs must focus upon the deep value present in Northwest Biotherapeutics stock!
The astute Robert Hefner agrees:
Our Northwest Biotherapeutics (NWBO) investee “partner” likely has just made one of the biggest breakthroughs in the history of cancer. We know that is a really big statement so why do we at GHK believe that is possible? Because we believe the doors through which major cancer breakthroughs must pass are the human immune system, immunotherapies and personalized vaccines and NWBO has just leaped through those doors with its personalized DCVax vaccine made from your own cells.
You can argue about trial statistics until the cows come home but the bottom line is 1) people living longer 2) quality of life during treatments and 3) the cost of treatments.
During NWBO’s 16-year Phase III trial to treat glioblastoma (GBM), one of the most difficult and lethal of all solid tumor cancers 1) more people lived longer, 2) it is safe with virtually no side effects occurring and 3) NWBO estimates treatments will cost about half as much as Standard of Care chemotherapy and radiation treatments. So for the first time ever, GBM patients can have hope! And can hope like prayer increase the effectiveness and energy of the immune system? We think so.
We are aware we stuck our necks out when we said “possibly one of the biggest breakthroughs in the history of cancer”. So we have listed below our three principle reasons so you can decide for yourself:
After 417 failed GBM trials treating 31,952 patents over decades, DCVax-L is first treatment that gives GBM patients a meaningful chance to live longer, some now living 9 to as many as 19 years and counting.
DCVax was conceived and created not for glioblastoma alone but as a personalized tool of your own immune system to defeat all solid tumor cancers and that’s 90% of all cancers.
Since DCVax’s creation NWBO has amassed an enormous rich databank containing masses of information on patients, treatments, and DCVax’s use against 15 different solid tumor cancers that has not yet been analyzed by artificial intelligence (AI). We believe that in the near future when these vast amounts of data and information are teamed with AI and some of the world’s leading scientists and doctors that future generations of DCVax vaccines and protocols will experience great leaps forward in effectiveness at lower and lower costs for 90% of all cancers.
So to sum up, we believe NWBO with its DCVax immunotherapy personalized vaccines has leaped through the doors and will play a vital role in humanities great drive to defeat cancer once and for all.
Dr. Ashkan is the genius behind this viral vid of him performing brain surgery while his patient was awakened to play the violin…mid-surgery. He told me he champions DCVax-L bc of trial data along with what he’s seen first-hand from his patients. $NWBOhttps://t.co/XFTeSPFtH5
— Wade Kovash (@wkovash) June 6, 2022
Watch one of the world’s preeminent neurosurgeons explain the significance of $NWBO ‘s Phase III trial of DCVax-L. The results are groundbreaking and represent an enormous advancement in one of the most tragic cancers. https://t.co/eQw5tAsivK
— Wade Kovash (@wkovash) June 6, 2022
From suck to blow!
I agree LP will be on Time Magazine.
I would rather see perp walks. There's a lot of money available without having those people as investors.
Hours before presenting Landmark Trial Data the Mafia cabal, figureheaded by obese edgelord Adam Feuerstein, began manipulation of NWBO stock. Had that not occurred we could be at $10 today. Management know they need to get off OTC. So in my opinion they're keeping their power dry until that one big day we hear about MHRA approval.
NICE allows up to 100K per QALY for orphan and rare diseases. They will certainly reimburse DCVax.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169141878
NWBO hold technology which could lead to the first trillion dollar biotechnology market capitalization. You can criticize my prediction all you want but that doesn't invalidate the market disrupting potential of DCVax.
Your attempts to consistently throw cold water on what should be a hot celebratory party after the Mechanism of Action talk at ASCO 2023 seems very telling.
I don't know why a shareholder would devote so much time towards trashing this great company, their life-saving technology, or the management team which delivered Landmark Trial Results.
I agree bio.
Landmark Trial Data
In fact Adam Feuerstein manipulated the stock on evening of 5/9 when he claimed Linda Liau was running away from NWBO.
In fact as you know the drug approval process isn't public, the SEC does not require disclosure of an application, thereby we could easily be in a rolling review process. Plenty of time for 2023 approval!
Short sellers collapsed the stock causing dilution. Perhaps you never read the groundbreaking lawsuit against every NYSE DMM?
DCVax has the ability to reach monumental market capitalization
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172073359
We are a day closer to billions in post-approval DCVax revenue as well as thousands of GBM patients saved every month once Sawston gets to full capacity.
Dave Innes was a portfolio manager. You can diminish the accomplishments of NWBO's world-class team but it really will not have any impact on the billions in revenue DCVax will bring after approval.
As I already posted Dave Innes managed nearly 200M portfolio which happens to be larger than anything anyone on this forum has spearheaded in their careers with the exception of perhaps Michael Bigger and Steve Derby. In my personal opinion, given his resume, he likely would have discussions with institutional investors which could be involved in equity partnerships coinciding with MAA approval and uplist.
Given his background as an institutional investor, I do not believe Dave was hired to manage the split personalities of mentally deranged retail shareholders.
Dave Innes managed nearly 200M portfolio which happens to be larger than anything anyone on this forum has spearheaded in their careers with the exception of perhaps Michael Bigger and Steve Derby.
Dave Innes will help secure a very large deal in my opinion but go ahead with your always incorrect conclusions.
If you spoke to Dave you would know he doesn't like being quoted on social media or forums precisely because many misconstrue his statements in an attempt to manipulate NWBO stock.
Overwhelming evidence of criminal manipulation occurring with NWBO stock.
Naked shorting happens all of the time.
https://www.sec.gov/news/press-release/2023-107
https://en.yna.co.kr/view/AEN20230308008700315
https://www.reuters.com/markets/asia/skorea-regulator-fines-two-firms-naked-shorts-under-stricter-law-2023-03-08/
https://www.barrons.com/advisor/articles/finra-ubs-fines-51664909400
https://www.financemagnates.com/institutional-forex/finra-penalizes-ubs-securities-25m-for-73000-naked-short-sales/
https://www.securitiesfinancetimes.com/securitieslendingnews/regulationarticle.php?article_id=219973&navigationaction=regulationnews&newssection=regulation
https://www.reuters.com/article/southkorea-markets-regulator/south-korean-regulator-names-foreign-firms-fined-for-naked-short-selling-idUKL1N34P0UH
https://www.wsj.com/articles/interactive-brokers-fined-5-5-million-for-naked-short-selling-violations-1534797834
Naked shorting happens all of the time.
So you're accusing Linda Liau, Stephen Toms, and the other 71 trial authors of fraud?
I think management have a lot to say but the historical, and likely contemporary, organized crime element involved in OTC chicanery means they're facing a media skeptical of leading new investors into this morass of manipulation.
Once we have an approval secured things should move very quickly as that's immediate revenue for a nimble biotech firm with minimal debt. We have a very large backlog of R&D efforts that I am sure the market will find very interesting. Attacking hundreds to thousands of protein targets without side effects isn't something which will remain under the radar for much longer.
You are free to censor yourself. I am not backing down from my predictions. I am here for $62. It will happen. Donate the money. I won't need it.
Many here thought we would be in a third tier journal, or no publication, instead we have JAMA.
Do not doubt this management team.
We have plenty of time left in 2023 for astronomical appreciation in our share price.
$62 still stands. Plenty of time left in 2023.
Good job!
Trillion dollar technology.
Bringing up Oceangate happens to be an appalling rhetorical device, in extremely bad taste, but that's par for the course, apparently. If there's an airplane crash, natural disaster, terrorist attack, or economic calamity I am sure some will seek to blame Linda Powers or draw irrational comparisons.
Can you imagine Dave Innes having to speak with these type of people every day?
Management did not have issues with Nasdaq! Short sellers collapsed their stock! They have been under manipulation for over 5 years, harassed, and sued without basis which cost shareholders millions to defend in court.
While all of this happened they still managed to deliver:
Landmark Trial Results
Innovative Manufacturing
Global Patent Protection
Soon:
Worldwide Approval
Additional Trials
How many other management teams navigated similar obstacles while creating such monumental outcomes?
None.